Lonza is one of the world’s largest companies for contract development and manufacturing, recognized for our reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and over 35 years of experience in mammalian cell culture.

In Lonza’s extensive contract development and manufacturing services portfolio, Lonza uses advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins. Their biologics offering spans from preclinical services, clinical drug product and drug substance and commercial supply in Mammalian, Microbial, ADCs / Bioconjugates, mRNA/LNPs and Cell & Gene Therapies.

Lonza works in partnership with customers of all sizes, from start-ups to large biotech and pharmaceutical companies, and can tailor our products and services to rapidly bring candidates to the clinic and products to market.